As shown in Figure 2A, highly expressed SMARCA4 is linked to poor prognosis for cancers including ACC (p = 0.00034), mesothelioma (MESO, p = 0.00017), sarcoma (SARC, p = 0.011), and SKCM (p = 0.037) of TCGA datasets. Here, SMARCA4 is linked to cancer.